Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Michael Kaufmann
Age : 57
Public asset : 27,924,111 USD
Country of residence : Unknown
Linked companies : Cardinal Health, Inc. - MSC Industrial Direct Co., Inc.

Biography of Michael Kaufmann 
Michael C. Kaufmann is on the board of MSC Industrial Direct Co., Inc. and Ohio Northern University and Chief Executive Officer & Director at Cardinal Health, Inc. and Member-Executive Board at Red Oak Sourcing. He received an undergraduate degree from Ohio Northern University.


Current positions of Michael Kaufmann 
Holdings of Michael Kaufmann 
Michael Kaufmann : Personal Network 
Most Read News 
10/15JACK DORSEY : Square CEO Dorsey says looking to build a bitcoin mining system - tweet
RE
10/12CATHIE WOOD : ARK Invest's Wood warns upcoming economic downturn in China 'obvious'
RE
10/11JAMIE DIMON : JPMorgan's Dimon blasts bitcoin as 'worthless', due for regulation
RE
10/17ELON MUSK : Tesla's Musk dials into Volkswagen executive conference
RE
10/13WARREN BUFFETT : Buffett-backed Nubank turns a profit in Brazil
RE
10/18MATTHEW MOULDING : THG's Moulding gives up 'golden share' after stock tumbles
RE
10/12JACK MA : Billionaire Alibaba founder Jack Ma reappears in Hong Kong - sources
RE
10/09ELON MUSK : First Berlin Teslas could come next month, Musk tells fans
RE
10/18BILL GATES : Electric vehicle battery startup ONE backed by BMW, Gates-led firm
RE
10/06CARL ICAHN : Stock Futures Point to Fresh Selloff on Wall Street
DJ
More news


© 2021 People and Ownership :   
Michael Kaufmann : Connections 


Latest news about Michael Kaufmann 
09/14Cardinal Health to Seek M&A
CI
03/09Cardinal Health Seeks Acquisitions
CI
2019Judge summons drug company CEOs to discuss opioid settlement
RE
More news